CHEK1 and cancer: To study the effect of the status of p53 on the DNA damage response to SFOM-0046, we assessed the activation of markers of the DNA damage checkpoints (ATR, ATM, Chk1, γ-H2AX) and HR in isogenic HCT116 (p53 +/+ and p53 −/−) cancer cell lines.